FDA decision: BBP-418 by Ml Bio Solutions Inc. (in 2026)
This market resolves based on whether the FDA grants full or accelerated approval for BBP-418 by Ml Bio Solutions Inc. in 2026.
KalshiEnds Dec 31, 2026Outcomes
Yes pays $1 if it happens · best price highlighted
| Outcome | Chance | 24h | Last 24h | Kalshi |
|---|---|---|---|---|
| a full approval or an accelerated approval | 91% | — | 93¢ |
a full approval or an accelerated approval
91%
—Yes price on Kalshi, last 2 weeks
Discussion
Posts and calls about this event
Live room
Connecting…Loading…
Sign in to chat in the room.